HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer

por Pang, Tony C. Y., Xu, Zhihong, Mekapogu, Alpha Raj, Pothula, Srinivasa, Becker, Therese, Corley, Susan, Wilkins, Marc R., Goldstein, David, Pirola, Romano, Wilson, Jeremy, Apte, Minoti
Publicado 2021

Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis

por Xu, Zhihong, Pang, Tony C. Y., Liu, Adele C., Pothula, Srinivasa P., Mekapogu, Alpha Raj, Perera, Chamini J., Murakami, Takashi, Goldstein, David, Pirola, Romano C., Wilson, Jeremy S., Apte, Minoti V.
Publicado 2020

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)

por Hosen, S. M. Zahid, Uddin, Md. Nazim, Xu, Zhihong, Buckley, Benjamin J., Perera, Chamini, Pang, Tony C. Y., Mekapogu, Alpha Raj, Moni, Mohammad Ali, Notta, Faiyaz, Gallinger, Steven, Pirola, Ron, Wilson, Jeremy, Ranson, Marie, Goldstein, David, Apte, Minoti
Publicado 2022